Marcus Rattray

Marcus Rattray

Auto-generated profile, based on publicly available information

Marcus Rattray

Reading School of Pharmacy, University of Reading, Reading, UK

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2001 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
CBCaterina Bendotti
Caterina Bendotti
MTMassimo Tortarolo
Massimo Tortarolo
SSSachin K. Suchak
Sachin K. Suchak
NCNovella Calvaresi
Novella Calvaresi
LCLucia Carvelli
Lucia Carvelli
TMTiziana Mennini
Tiziana Mennini
Glutamate‐induced excitotoxicity is suggested to play a central role in the development of amyotrophic lateral sclerosis (ALS), although it is still unclear whether it represents a primary cause in the cascade leading to motor neurone death. We used western blotting, immunocytochemistry and in situ hybridization to examine the expression of GLT‐1 in transgenic mice carrying a mutated (G93A) human copper–zinc superoxide dismutase (TgSOD1 G93A), which closely mimic the features of ALS. We observed a progressive decrease in the immunoreactivity of the glial glutamate transporter (GLT‐1) in the ventral, but not in the dorsal, horn of lumbar spinal cord. This effect was specifically found in 14‐ and 18‐week‐old mice that had motor function impairment, motor neurone loss and reactive astrocytosis. No changes in GLT‐1 were observed at 8 weeks of age, before the appearance of clinical symptoms. Decreases in GLT‐1 were accompanied by increased glial fibrillary acidic protein (GFAP) levels and no change in the levels of GLAST, another glial glutamate transporter. The glutamate concentration in the cerebrospinal fluid (CSF) of TgSOD1 G93A mice was not modified at any of the time points examined, compared with age‐matched controls. These findings indicate that the loss of GLT‐1 protein in ALS mice selectively occurs in the areas affected by neurodegeneration and reactive astrocytosis and it is not associated with increases of glutamate levels in CSF. The lack of changes in GLT‐1 at the presymptomatic stage suggests that glial glutamate transporter reduction is not a primary event leading to motor neurone loss.

9 January 2007 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
HSHagen Schroeter
Hagen Schroeter
PBParmvir Bahia
Parmvir Bahia
JSJeremy P. E. Spencer
Jeremy P. E. Spencer
OSOlivia Sheppard
Olivia Sheppard
MRMarcus Rattray
Marcus Rattray
RWRobert Justin Williams
Robert Justin Williams
Emerging evidence suggests that the cellular actions of flavonoids relate not simply to their antioxidant potential but also to the modulation of protein kinase signalling pathways. We investigated in primary cortical neurons, the ability of the flavan‐3‐ol, (‐)epicatechin, and its human metabolites at physiologically relevant concentrations, to stimulate phosphorylation of the transcription factor cAMP‐response element binding protein (CREB), a regulator of neuronal viability and synaptic plasticity. (‐)Epicatechin at 100–300 nmol/L stimulated a rapid, extracellular signal‐regulated kinase (ERK)‐ and PI3K‐dependent, increase in CREB phosphorylation. At micromolar concentrations, stimulation was no longer apparent and at the highest concentration tested (30 μmol/L) (‐)epicatechin was inhibitory. (‐)Epicatechin also stimulated ERK and Akt phosphorylation with similar bell‐shaped concentration‐response characteristics. The human metabolite 3′‐O‐methyl‐(‐)epicatechin was as effective as (‐)epicatechin at stimulating ERK phosphorylation, but (‐)epicatechin glucuronide was inactive. (‐)Epicatechin and 3′‐O‐methyl‐(‐)epicatechin treatments (100 nmol/L) increased CRE‐luciferase activity in cortical neurons in a partially ERK‐dependent manner, suggesting the potential to increase CREB‐mediated gene expression. mRNA levels of the glutamate receptor subunit GluR2 increased by 60%, measured 18 h after a 15 min exposure to (‐)epicatechin and this translated into an increase in GluR2 protein. Thus, (‐)epicatechin has the potential to increase CREB‐regulated gene expression and increase GluR2 levels and thus modulate neurotransmission, plasticity and synaptogenesis.

28 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Catarina RendeiroCatarina Rendeiro
Catarina Rendeiro
DVDavid Vauzour
David Vauzour
MRMarcus Rattray
Marcus Rattray
PWPierre Waffo-Téguo
Pierre Waffo-Téguo
JMJean Michel Mérillon
Jean Michel Mérillon
JSJeremy Spencer
Jeremy Spencer
Evidence suggests that flavonoid-rich foods are capable of inducing improvements in memory and cognition in animals and humans. However, there is a lack of clarity concerning whether flavonoids are the causal agents in inducing such behavioral responses. Here we show that supplementation with pure anthocyanins or pure flavanols for 6 weeks, at levels similar to that found in blueberry (2% w/w), results in an enhancement of spatial memory in 18 month old rats. Pure flavanols and pure anthocyanins were observed to induce significant improvements in spatial working memory (p = 0.002 and p = 0.006 respectively), to a similar extent to that following blueberry supplementation (p = 0.002). These behavioral changes were paralleled by increases in hippocampal brain-derived neurotrophic factor (R = 0.46, p<0.01), suggesting a common mechanism for the enhancement of memory. However, unlike protein levels of BDNF, the regional enhancement of BDNF mRNA expression in the hippocampus appeared to be predominantly enhanced by anthocyanins. Our data support the claim that flavonoids are likely causal agents in mediating the cognitive effects of flavonoid-rich foods.

1 May 1998 in NeuroReport
Verified
Journal Article
Closed access
DODaniela Oddiah
Daniela Oddiah
PAPraveen Anand
Praveen Anand
SMStephen B. McMahon
Stephen B. McMahon
MRMarcus Rattray
Marcus Rattray
NERVE growth factor (NGF) is a mediator of hyperalgesia and has been previously associated with sensory and reflex changes after inflammation of the urinary bladder. A sensitive assay was developed to examine neurotrophin gene expression after bladder inflammation by turpentine, which causes a short-lived inflammatory response. Two hours, but not 6 or after induction of inflammation, there were significant increases in levels of NGF, brain-derived neurotrophic factor and neurotrophin-3 mRNAs. NGF immunoreactivity was elevated with a similar time course to its mRNA. Our results suggest that during bladder inflammation, endogenous NGF is rapidly up-regulated and released to mediating sensory and reflex changes. Brain-derived neurotrophic factor and neurotrophin-3 may also have a role in the inflammatory response.

1 December 2000 in Molecular Brain Research
Verified
Journal Article
Closed access
PKPaul J Kenny
Paul J Kenny
SFSandra E File
Sandra E File
MRMarcus Rattray
Marcus Rattray

1 January 2012 in Neurochemistry International
Verified
Journal Article
Closed access
MCMarica Carbone
Marica Carbone
SDSusan Duty
Susan Duty
MRMarcus Rattray
Marcus Rattray